A GHRH receptor agonist studied for stimulating the body's own pulsatile growth hormone release.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 200 mcg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 2 units |
| 10 mg | 1 mL | 10 mg/mL | 2 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 200 mcg. At 10 mg/mL, that draws to 2 units on a U-100 insulin syringe.
Binds GHRH receptors in the anterior pituitary to trigger natural pulsatile growth hormone secretion and downstream IGF-1 production. It enhances endogenous output rather than supplying hormone directly.
Sermorelin is commonly taken in the evening.
Add 0.5 mL of bacteriostatic water to a 5 mg Sermorelin vial for a 10 mg/mL solution.
A common Sermorelin starting dose is 200 mcg, which at 10 mg/mL draws to 2 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the Sermorelin vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.
Add 0.5 mL of bacteriostatic water to a 5 mg Sermorelin vial for a 10 mg/mL solution. A 200 mcg dose then draws to 2 units on a U-100 insulin syringe.
Add 1 mL of bacteriostatic water to a 10 mg Sermorelin vial for a 10 mg/mL solution. A 200 mcg dose then draws to 2 units on a U-100 insulin syringe.